Texas Permanent School Fund’s Tvardi Therapeutics TVRD Stock Holding History

Texas Permanent School Fund’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,347	Closed	-$238K	–	1543
2023 Q1	$238K	Buy	1,347 +635	+89%	+$213K	﹤0.01%	1508
2022 Q4	$275K	Sell	712 -183	-20%	-$69.5K	﹤0.01%	1464
2022 Q3	$302K	Buy	895 +53	+6%	+$19.2K	﹤0.01%	1444
2022 Q2	$277K	Buy	842 +17	+2%	+$5.96K	﹤0.01%	1464
2022 Q1	$361K	Sell	825 -21	-2%	-$8.62K	﹤0.01%	1452
2021 Q4	$371K	Sell	846 -19	-2%	-$9.55K	﹤0.01%	1460
2021 Q3	$481K	Sell	865 -26	-3%	-$13K	0.01%	1421
2021 Q2	$458K	Buy	+891	New	+$565K	0.01%	1432

Other funds holding TVRD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Texas Permanent School Fund's TVRD Position: Q2 2023 in Review

Texas Permanent School Fund sold out of Tvardi Therapeutics (TVRD) in Q2 2023, closing a stake of 1,347 shares — an estimated $238K sold.

Texas Permanent School Fund first reported a position in TVRD in Q2 2021 and held it in 8 quarters. The position peaked at $481K in Q3 2021. 137 funds tracked by Wall St. Rank hold TVRD as of Q2 2023.

Texas Permanent School Fund reported no remaining Tvardi Therapeutics position as of Q2 2023 after selling out during the quarter.
Texas Permanent School Fund sold 1,347 Tvardi Therapeutics shares in Q2 2023, an estimated $238K.
Texas Permanent School Fund first reported a position in Tvardi Therapeutics in Q2 2021 and held it in 8 quarters.
Texas Permanent School Fund's Tvardi Therapeutics position peaked at $481K in Q3 2021.
137 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2023.

Based on Texas Permanent School Fund's 13F filing for Q2 2023, filed 7 Aug 2023.